Additionally, serum sarcosine exhibited the largest area under the curve (AUC) for predicting low-grade, low-PSA PCa, suggesting its potential in diagnosing PCa among individuals with normal PSA levels and identifying candidates suitable for non-aggressive therapies and active surveillance [43]. Here, KLK3 is linked to posterior cortical atrophy.